EEF1A2 and cancer: The precision-driven diagnostic and treatment strategies for Tn/STn antigens, resulting from the synergistic intersection of glycoscience, immunology, and nanotechnology, hold the potential to drive revolutionary breakthroughs in cancer treatment.